Original Article

Split Viewer

Korean J Hematol 2011; 46(2):

Published online June 21, 2011

https://doi.org/10.5045/kjh.2011.46.2.128

© The Korean Society of Hematology

Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow

Gak-Won Yun1, Young-Jun Yang1, Ik-Chan Song1, Seung-Woo Baek1, Kyu-Seop Lee1, Hyo-Jin Lee1, Hwan-Jung Yun1, Kye-Chul Kwon2, Samyong Kim1, and Deog-Yeon Jo1*

1Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

2Department of Laboratory Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

Correspondence to : Correspondence to Deog-Yeon Jo, M.D., Ph.D. Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel: +82-42-280-7162, Fax: +82-42-257-5753, deogyeon@cnu.ac.kr

Received: January 9, 2011; Revised: March 6, 2011; Accepted: May 17, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Hypocellularity of bone marrow (BM), not associated with significant dyshematopoiesis, is often found in patients with isolated thrombocytopenia, but its clinical implications have not been studied. We prospectively studied the clinical features and natural history of these patients.

Methods

Adults with isolated thrombocytopenia (platelet counts <100×109/L) in the absence of dyshematopoiesis, cytogenetic abnormalities, or megakaryocytic hyperplasia and who had BM hypocellularity (below 30% in patients aged less than 60 years; below 20% in patients aged 60 years or more) were enrolled at Chungnam National University Hospital between January 2002 and December 2006. They were monitored regularly for changes in platelet counts or development of additional cytopenia.

Results

Twenty patients (17 men and 3 women) were enrolled in the study. The median age was 29 years (range, 18-70 years). At initial presentation, the platelet counts ranged from 12×109/L to 99×109/L (median, 63×109/L) and were >50×109/L in 16 patients (80%). BM cellularity ranged from 5% to 25% (median, 15%) and was ≤10% in 6 patients (30%). During the median 48-month follow-up (range, 12-90 months), platelet counts of 3 of the 20 patients recovered to normal levels (>150×109/L) after 12, 56 and 66 months. Three patients developed pancytopenia after 11, 70 and 90 months. Two patients were consistent with moderate aplastic anemia, and 1 was confirmed as having refractory cytopenia with multilineage dysplasia. In the remainder of the patients, platelet counts remained unchanged.

Conclusion

Isolated thrombocytopenia accompanied by hypocellular marrow encompasses a group of heterogeneous conditions.

Keywords Thrombocytopenia, Idiopathic thrombocytopenic purpura, Bone marrow, Aplastic anemia, Myelodysplastic syndromes

Article

Original Article

Korean J Hematol 2011; 46(2): 128-134

Published online June 21, 2011 https://doi.org/10.5045/kjh.2011.46.2.128

Copyright © The Korean Society of Hematology.

Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow

Gak-Won Yun1, Young-Jun Yang1, Ik-Chan Song1, Seung-Woo Baek1, Kyu-Seop Lee1, Hyo-Jin Lee1, Hwan-Jung Yun1, Kye-Chul Kwon2, Samyong Kim1, and Deog-Yeon Jo1*

1Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

2Department of Laboratory Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

Correspondence to: Correspondence to Deog-Yeon Jo, M.D., Ph.D. Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, 33, Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel: +82-42-280-7162, Fax: +82-42-257-5753, deogyeon@cnu.ac.kr

Received: January 9, 2011; Revised: March 6, 2011; Accepted: May 17, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Hypocellularity of bone marrow (BM), not associated with significant dyshematopoiesis, is often found in patients with isolated thrombocytopenia, but its clinical implications have not been studied. We prospectively studied the clinical features and natural history of these patients.

Methods

Adults with isolated thrombocytopenia (platelet counts <100×109/L) in the absence of dyshematopoiesis, cytogenetic abnormalities, or megakaryocytic hyperplasia and who had BM hypocellularity (below 30% in patients aged less than 60 years; below 20% in patients aged 60 years or more) were enrolled at Chungnam National University Hospital between January 2002 and December 2006. They were monitored regularly for changes in platelet counts or development of additional cytopenia.

Results

Twenty patients (17 men and 3 women) were enrolled in the study. The median age was 29 years (range, 18-70 years). At initial presentation, the platelet counts ranged from 12×109/L to 99×109/L (median, 63×109/L) and were >50×109/L in 16 patients (80%). BM cellularity ranged from 5% to 25% (median, 15%) and was ≤10% in 6 patients (30%). During the median 48-month follow-up (range, 12-90 months), platelet counts of 3 of the 20 patients recovered to normal levels (>150×109/L) after 12, 56 and 66 months. Three patients developed pancytopenia after 11, 70 and 90 months. Two patients were consistent with moderate aplastic anemia, and 1 was confirmed as having refractory cytopenia with multilineage dysplasia. In the remainder of the patients, platelet counts remained unchanged.

Conclusion

Isolated thrombocytopenia accompanied by hypocellular marrow encompasses a group of heterogeneous conditions.

Keywords: Thrombocytopenia, Idiopathic thrombocytopenic purpura, Bone marrow, Aplastic anemia, Myelodysplastic syndromes

Fig 1.

Figure 1.

Relationship among laboratory parameters in patients with isolated thrombocytopenia accompanied by hypocellular marrow. Weak positive correlations were observed between serum erythropoietin (EPO) levels and mean corpuscular volume (MCV) (B) and between bone marrow (BM) cellularity and platelet counts (C). No correlation was observed between serum EPO levels and platelet counts (A), between BM cellularity and Hb levels (D), or between BM cellularity and serum EPO levels (E).

Blood Research 2011; 46: 128-134https://doi.org/10.5045/kjh.2011.46.2.128

Fig 2.

Figure 2.

Representative bone marrow biopsy findings (hematoxylin and eosin [H&E] stain, ×100). (A) Marked hypocellularity with even cellular distribution (from UPN 1). (B) Marked hypocellularity with focally uneven cellular distribution (UPN 15). (C) Moderate hypocellularity with even cellular distribution (from UPN 14).

Blood Research 2011; 46: 128-134https://doi.org/10.5045/kjh.2011.46.2.128

Table 1 . Patient characteristics and natural history..

a)Time to the events (normalization of platelet counts or development of pancytopenia)..

Abbreviations: ANC, absolute neutrophil counts; MCV, mean corpuscular volume; BM, bone marrow cellularity; NC, not changed; MAA, moderate aplastic anemia; RCMD, refractory cytopenia with multilineage dysplasia..


Table 2 . Summary of laboratory data at initial presentation (N=20)..

Abbreviation: MCV, mean corpuscular volume..


Table 3 . Natural history of patientsa) (N=20)..

a)Patients were followed up for a median of 48 months (range, 12-90 months)..

Abbreviation: RCMD, refractory cytopenia with multilineage dysplasia..


Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download